Planned Maintenance: Some services may turn out to be unavailable from 15th January, 2026 to 16th January, 2026. We apologize for the inconvenience!

4ZZB image
Deposition Date 2015-05-22
Release Date 2016-03-02
Last Version Date 2024-11-13
Entry Detail
PDB ID:
4ZZB
Title:
The GLIC pentameric Ligand-Gated Ion Channel Locally-closed form complexed to xenon
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
3.40 Å
R-Value Free:
0.22
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Proton-gated ion channel
Gene (Uniprot):glvI
Mutagens:C27S K33C L246C
Chain IDs:A, B, C, D, E
Chain Length:317
Number of Molecules:5
Biological Source:Gloeobacter violaceus PCC 8105
Primary Citation
Structural Basis for Xenon Inhibition in a Cationic Pentameric Ligand-Gated Ion Channel.
Plos One 11 e0149795 e0149795 (2016)
PMID: 26910105 DOI: 10.1371/journal.pone.0149795

Abstact

GLIC receptor is a bacterial pentameric ligand-gated ion channel whose action is inhibited by xenon. Xenon has been used in clinical practice as a potent gaseous anaesthetic for decades, but the molecular mechanism of interactions with its integral membrane receptor targets remains poorly understood. Here we characterize by X-ray crystallography the xenon-binding sites within both the open and "locally-closed" (inactive) conformations of GLIC. Major binding sites of xenon, which differ between the two conformations, were identified in three distinct regions that all belong to the trans-membrane domain of GLIC: 1) in an intra-subunit cavity, 2) at the interface between adjacent subunits, and 3) in the pore. The pore site is unique to the locally-closed form where the binding of xenon effectively seals the channel. A putative mechanism of the inhibition of GLIC by xenon is proposed, which might be extended to other pentameric cationic ligand-gated ion channels.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback